Jacobi Capital Management LLC Bio Xcel Therapeutics, Inc. Transaction History

Jacobi Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $3,018 - $5,263	-150 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$17.62 - $58.71 $2,096 - $6,986	119 Added 383.87%	150 $8,000
Q2 2020 Jul 27, 2020	SELL	$17.62 - $58.71 $2,096 - $6,986	-119 Reduced 79.33%	31 $8,000
Q1 2020 Apr 24, 2020	BUY	$12.26 - $41.14 $1,839 - $6,171	150 New	150 $3,000

8.69M

22.2K

27.7K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $64.7M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.